APA (7th ed.) Citation

Li, J., Shu, L., Jiang, Q., Feng, B., Bi, Z., Zhu, G., . . . Wu, J. Oridonin ameliorates renal fibrosis in diabetic nephropathy by inhibiting the Wnt/β-catenin signaling pathway. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Li, Jushuang, Lan Shu, Qianqian Jiang, Baohong Feng, Zhimin Bi, Geli Zhu, Yanxia Zhang, Xiangyou Li, and Jun Wu. Oridonin Ameliorates Renal Fibrosis in Diabetic Nephropathy by Inhibiting the Wnt/β-catenin Signaling Pathway. Taylor & Francis Group.

MLA (9th ed.) Citation

Li, Jushuang, et al. Oridonin Ameliorates Renal Fibrosis in Diabetic Nephropathy by Inhibiting the Wnt/β-catenin Signaling Pathway. Taylor & Francis Group.